ANI Pharmaceuticals (ANIP) has a market capitalization of $1.6B, based on 22.97M shares at a price of $70.08 (down 1.3% today).
| DATE | CLOSE | VOLUME | OUTSTANDING | MARKET CAP |
|---|---|---|---|---|
October 2026 | $70.84 | 3,304,599 | 22,970,352 | $1,627,219,735.68 |
September 2026 | $72.65 | 8,840,400 | 21,915,000 | $1,592,124,750.00 |
August 2026 | $73.25 | 8,796,449 | 21,915,000 | $1,605,273,750.00 |
July 2026 | $79.24 | 6,151,822 | 21,915,000 | $1,736,544,600.00 |
June 2026 | $82.78 | 6,972,000 | 21,915,000 | $1,814,123,700.00 |
May 2026 | $78.51 | 8,286,100 | 21,915,000 | $1,720,546,650.00 |
April 2026 | $79.45 | 7,047,000 | 21,915,000 | $1,741,146,750.00 |
March 2026 | $76.90 | 8,205,942 | 21,544,000 | $1,656,733,600.00 |
February 2026 | $73.90 | 6,256,836 | 21,544,000 | $1,592,101,600.00 |
January 2026 | $81.85 | 11,347,922 | 21,544,000 | $1,763,376,400.00 |
December 2025 | $78.94 | 9,074,046 | 21,228,000 | $1,675,738,320.00 |
November 2025 | $84.85 | 8,581,757 | 21,228,000 | $1,801,195,800.00 |
October 2025 | $90.60 | 7,634,519 | 21,228,000 | $1,923,256,800.00 |
September 2025 | $91.60 | 7,830,398 | 21,093,000 | $1,932,118,800.00 |
August 2025 | $93.50 | 15,310,412 | 21,093,000 | $1,972,195,500.00 |
July 2025 | $63.35 | 6,690,354 | 21,093,000 | $1,336,241,550.00 |
June 2025 | $65.25 | 5,964,040 | 20,308,000 | $1,325,097,000.00 |
May 2025 | $58.72 | 9,129,025 | 20,308,000 | $1,192,485,760.00 |
April 2025 | $70.82 | 8,562,655 | 20,308,000 | $1,438,212,560.00 |
March 2025 | $66.95 | 7,791,934 | 20,046,000 | $1,342,079,700.00 |
February 2025 | $61.89 | 4,747,607 | 20,046,000 | $1,240,646,940.00 |
January 2025 | $58.64 | 3,452,363 | 20,046,000 | $1,175,497,440.00 |
December 2024 | $55.28 | 6,111,627 | 19,445,000 | $1,074,919,600.00 |
November 2024 | $57.23 | 6,039,814 | 19,445,000 | $1,112,837,350.00 |
October 2024 | $57.25 | 4,145,833 | 19,445,000 | $1,113,129,025.00 |